diltiazem has been researched along with Liver Dysfunction in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, W; Farricielli, L | 1 |
| Hunt, CA; Kim, SH; Park, S; Roberts, MS; Ropella, GE | 1 |
| Aomatsu, Y; Fukuoka, T; Hisanaga, M; Horikawa, M; Kanehiro, H; Kido, K; Nakajima, Y; Taki, J; Wada, T; Yoshimura, A | 1 |
| Farghali, H; Kmonícková, E; Lotková, H; Martínek, J | 1 |
| Liang, D; Thurman, RG | 1 |
| Deakin, CD; Fagan, EA; Gove, CD; Tredger, JM; Williams, R | 1 |
| Colombo, E; Romanò, M; Spinelli, A | 1 |
| Lauterburg, BH | 1 |
| Bova, S; Cargnelli, G; Ferrari, M; Moretto, R; Padrini, R; Piovan, D | 1 |
| Kuhlmann, J | 1 |
| Martre, H; Singlas, E; Taburet, AM | 1 |
1 review(s) available for diltiazem and Liver Dysfunction
| Article | Year |
|---|---|
[Clinical pharmacology of calcium inhibitors].
Topics: Age Factors; Animals; Bepridil; Biological Availability; Biotransformation; Calcium Channel Blockers; Diltiazem; Dogs; Half-Life; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Liver Diseases; Metabolic Clearance Rate; Nifedipine; Perhexiline; Protein Binding; Pyrrolidines; Rats; Tissue Distribution; Verapamil | 1985 |
1 trial(s) available for diltiazem and Liver Dysfunction
| Article | Year |
|---|---|
Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin.
Topics: Aged; Benzazepines; Clinical Trials as Topic; Digitoxin; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Heart Diseases; Humans; Kidney; Kidney Diseases; Kinetics; Liver Diseases; Male; Middle Aged; Nifedipine; Radioimmunoassay; Verapamil | 1985 |
9 other study(ies) available for diltiazem and Liver Dysfunction
| Article | Year |
|---|---|
Hypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusion.
Topics: Acute Kidney Injury; Aged; Atrial Fibrillation; Diltiazem; Hepatitis; Humans; Hypotension; Hypoxia; Liver Diseases; Liver Failure, Acute; Male; Thrombocytopenia; Vasodilator Agents | 2013 |
Tracing multiscale mechanisms of drug disposition in normal and diseased livers.
Topics: Animals; Chemical and Drug Induced Liver Injury; Diltiazem; Disease Models, Animal; In Vitro Techniques; Liver; Liver Diseases; Liver Diseases, Alcoholic; Male; Models, Biological; Monte Carlo Method; Pharmaceutical Preparations; Rats; Rats, Wistar; Tissue Distribution | 2010 |
Protective effect of the calcium channel blocker diltiazem on hepatic function following warm ischemia.
Topics: Animals; Blood Pressure; Diltiazem; Dogs; Female; Femoral Artery; Hot Temperature; Ischemia; Ketone Bodies; Lactates; Lactic Acid; Liver; Liver Diseases; Male | 1993 |
Evaluation of calcium channel blockers as potential hepatoprotective agents in oxidative stress injury of perfused hepatocytes.
Topics: Adenosine Triphosphatases; Animals; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Diltiazem; Hepatocytes; L-Lactate Dehydrogenase; Lipid Peroxides; Liver Diseases; Male; Oxidative Stress; Oxygen Consumption; Perfusion; Rats; Rats, Wistar; tert-Butylhydroperoxide; Verapamil | 2000 |
Protective effects of the calcium antagonists diltiazem and TA3090 against hepatic injury due to hypoxia.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Female; Hypoxia; Ischemia; L-Lactate Dehydrogenase; Liver; Liver Diseases; Oxygen; Rats; Rats, Sprague-Dawley; Trypan Blue | 1992 |
Delayed calcium channel blockade with diltiazem reduces paracetamol hepatotoxicity in mice.
Topics: Acetaminophen; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Administration Schedule; Liver Diseases; Liver Regeneration; Male; Mice; Nifedipine | 1991 |
[Changes in liver enzymes during treatment with diltiazem. Description of 2 cases].
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Diltiazem; gamma-Glutamyltransferase; Humans; Liver Diseases; Male; Middle Aged | 1987 |
[Clinical pharmacology of calcium antagonists].
Topics: Aging; Arrhythmias, Cardiac; Biological Availability; Calcium Channel Blockers; Diltiazem; Drug Interactions; Half-Life; Heart Failure; Humans; Kidney; Liver; Liver Diseases; Nifedipine; Verapamil | 1987 |
Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers.
Topics: Aging; Animals; Calcium Channel Blockers; Diltiazem; Drug Administration Schedule; Guinea Pigs; Humans; Isomerism; Liver; Liver Diseases; Monitoring, Physiologic; Nifedipine; Phenotype; Verapamil | 1987 |